-
Technology
-
Product
-
-
Company
PREANALYTICAL EXCELLENCE
Blood Gas Preanalytical Errors:
Where Quality Begins
Up to 75% of blood gas errors originate in the preanalytical phase1. From air bubbles to heparin interference and delayed analysis—every step matters. MeterOmega redefines preanalytical control with micro‑volume precision, lyophilized heparin, and capillary integrity.
The Invisible Crisis
Preanalytical phase:weakest link in blood gas testing
Blood gas results guide life‑sustaining decisions in ICU, ED, and OR. Yet, the preanalytical phase—sampling, handling, anticoagulation—is the most error‑prone. Unlike analytical QC, preanalytical variables are often overlooked, leading to misdiagnosis, delayed treatment, and unnecessary redraws.
75% of blood gas errors are preanalytical
Bonini et al. (2002) demonstrated that preanalytical mistakes dominate laboratory errors. In critical care, this translates directly to patient harm.
CLSI C46-A2 and IFCC guidelines emphasize strict sample handling, yet many devices still introduce bias through excess heparin, air bubbles, and volume mismatches.
>62%
of all laboratory errors are preanalytical (Carraro et al.) — blood gases are particularly vulnerable due to living cells, oxygen consumption, and anticoagulant sensitivity.
Main preanalytical villains:
✔ Air bubbles / room air contamination
✔ Heparin overuse & electrolyte binding
✔ Venous admixture / improper puncture
✔ Delayed analysis & temperature mismanagement
✔ Hemolysis from vigorous mixing
✔ Wrong sample volume → dilution error
CLINICAL WORKFLOW ESSENTIALS
Best Practice Guide: From Patient to Analyzer
Simple steps to avoid the most common preanalytical traps. Follow these recommendations to ensure sample integrity and accurate results — especially when using MeterOmega devices designed to minimize error.
Patient & Puncture
Immediate Handling
Transport & Storage
Before Analysis
Patient prep
ID, steady state, site
Puncture & collect
25G thin-wall, automatic fill
No mixing*
*MeterOmega lyo‑heparin
Transport ≤30′
RT or ice if delayed
Analyzer load
Bubble‑free, clot‑free
TECHNOLOGY SPOTLIGHT
CapillaryABG™: zero bubbles, pure sample
Capillary tubes eliminate the single largest preanalytical interferent: air bubbles. When blood enters a capillary by controlled negative pressure/self‑filling, no air pocket remains. In contrast, syringe systems often trap micro‑bubbles that equilibrate with blood, altering pO₂, pCO₂, and pH unpredictably.
MeterOmega’s capillary samplers also feature a proprietary flow‑valve & flow‑plug that stops blood automatically at the exact volume. The result is a bubble‑free, homogenous sample ready for direct analyzer aspiration—no manual bubble expulsion, no risk of oxygen contamination.
CLSI H11-A4 & IFCC guidance: “Exposure of blood to atmosphere can markedly affect pO₂, pCO₂, and ionized calcium.” Capillary sampling with integrated venting (without air interface) preserves true patient values.
SyringeABG™: advanced venting, no hidden cavities
For users preferring a syringe format, MeterOmega SyringeABG™ incorporates a patented high‑flow hydrophobic vent that allows air to escape but seals instantly when blood reaches the filter. This design prevents air dead space and eliminates the need for post‑draw bubble removal. Unlike conventional vents that retain air pockets, our layered vent structure ensures complete gas evacuation.
Together with lyophilized heparin coating, the SyringeABG™ delivers a preanalytical profile identical to capillary systems — no bubbles, no mixing trauma, no hemolysis.
Advantage: No “milking” or vigorous mixing — reduces hemolysis risk (false K⁺ elevation) by >80% compared to traditional syringes.
MYTH BUSTING
“Bigger sample = safer result” — a dangerous misconception
Some believe large blood volumes (1.6 mL) “dilute” errors, but the opposite is true: excess volume magnifies heparin mass, dilution, and unnecessary blood loss.
The dilution trap
Conventional syringes often require 1.6 mL or more because they rely on high‑dose heparin (>50 IU/mL) to ensure anticoagulation. Larger blood volume attempts to “dilute” the heparin load, but it cannot eliminate interference: total heparin mass remains high, and electrolyte binding (Ca²⁺, Na⁺, K⁺) persists. Moreover, collecting 1.6 mL from neonates, elderly, or hypotensive patients is both difficult and clinically harmful.
Typical analyzer sample volume requirements
Brand
Model
Min volume (µL)
Werfen
GEM5000
150
Radiometer
ABL90
65
Roche
Cobas b 123
123
Siemens
RAPIDPoint 500
150
Analyzers need only 65–150 µL. Forcing 1.6 mL does not improve accuracy—it increases heparin load and risks iatrogenic anemia. MeterOmega’s micro‑volume design matches exactly what analyzers need: no more, no less.
Dual quantification: heparin & blood in perfect harmony
MeterOmega CapillaryABG™ and SyringeABG™ series are engineered with fixed micro‑volume sampling (230–310 µL depending on type). Lyophilized heparin content is pre‑calibrated to the exact sample volume, delivering ≤15 IU/mL final concentration — meeting IFCC/CLSI optimal recommendations. This eliminates the “variable heparin/blood ratio” problem seen in traditional syringes where under‑ or over‑fill changes the effective heparin concentration.
Key advantage: predictable, constant heparin concentration regardless of filling precision.
No need to “guess” the right volume; each device delivers a predefined blood amount with precisely matched heparin. The result: minimal electrolyte bias, no clots, and maximum sample integrity.
INTERNATIONAL GUIDELINES
Heparin & sample volume: the right balance
Leading organizations set strict limits: low heparin concentration is non‑negotiable for accurate electrolytes. MeterOmega’s dual‑quantification approach goes beyond “low heparin”—it ensures consistent heparin/blood ratio every time.
IFCC 2018
“Final concentration of sodium or lithium heparin ≤15 IU/mL blood” for reliable Ca²⁺, Na⁺, K⁺ measurement.
CLSI C46-A2
“Special heparin preparations are preferable” and final concentration <20 IU/mL to minimize binding.
≤15 IU/mL
MeterOmega lyophilized heparin delivers <15 IU/mL final concentration irrespective of fill.
Total Preanalytical Solution
CapillaryABG™ & SyringeABG™ — engineered for sample truth
Whether you prefer capillary micro‑sampling or a syringe with advanced venting, both platforms share the same philosophy: minimal heparin, precise volume, and uncompromised integrity. Backed by ISO 13485 and CE MDR, trusted in over 80 markets.
230–310 µL
Bubble‑free, flow‑valve
≤15 IU/mL lyo‑heparin
0.5–1 mL options
Vented plunger, no air space
Lyophilized heparin <15 IU/mL
Veterinary micro‑sampling
Same preanalytical excellence
Bonini P et al. Errors in laboratory medicine. Clin Chem 2002;48(5):691-8.
van Berkel M, Scharnhorst V. Electrolyte-balanced heparin bias. Clin Chem Lab Med 2011;49(2):249-52.
CLSI C46-A2, IFCC Point of Care Testing 2018. Analyzer data from manufacturer specifications.
MeterOmega Medical Wuhan LTD
Address: NO.23-1-3 Gezhouba Suncity, GaoXin 4th road, East Lake development zone, Wuhan, China.
Tel: +86 (0) 27 6552 4498
Email: info@meteromega.com
Website: www.meteromega.com.cn
Hubei MeterOmega Technology LTD.
1F&2F, Building 3, Biomedical industrial Park, Jianqiu 5th Road, Duodao District, 448000, Jingmen City, Hubei Province, PEOPLE'S REPUBLIC OF CHINA
METER OMEGA CO., LTD.
Address: 1/126 Venis Di Iris, Soi Vatcharapol2/7, Tharaeng, Bangken Dist, Bangkok,10220,Thailand
Tel: +66962837333